Accessibility Menu
 
P3 Health Partners logo

P3 Health Partners

(NASDAQ) PIII

Current Price$2.57
Market Cap$8.47M
Since IPO (2021)-99%
5 YearN/A
1 Year-72%
1 Month-3%

P3 Health Partners Financials at a Glance

Market Cap

$8.47M

Revenue (TTM)

$1.46B

Net Income (TTM)

$147.95M

EPS (TTM)

$-45.20

P/E Ratio

-0.06

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$2.57

Volume

100

Open

$2.57

Previous Close

$2.57

Daily Range

$2.57 - $2.57

52-Week Range

$1.52 - $11.30

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About P3 Health Partners

Industry

Healthcare Providers and Services

Employees

320

CEO

Aric Coffman, MD, MBA

Headquarters

Henderson, NV 89074, US

PIII Financials

Key Financial Metrics (TTM)

Gross Margin

-10%

Operating Margin

-19%

Net Income Margin

-10%

Return on Equity

-257%

Return on Capital

-2%

Return on Assets

-23%

Earnings Yield

-16.67%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$8.47M

Shares Outstanding

3.29M

Volume

100

Short Interest

0.00%

Avg. Volume

85.40K

Financials (TTM)

Gross Profit

$144.32M

Operating Income

$270.30M

EBITDA

$186.14M

Operating Cash Flow

$91.24M

Capital Expenditure

$79.00K

Free Cash Flow

$91.16M

Cash & ST Invst.

$25.01M

Total Debt

$287.29M

P3 Health Partners Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$384.81M

+3.8%

Gross Profit

$469.80M

-226.7%

Gross Margin

-1.22%

N/A

Market Cap

$8.47M

N/A

Market Cap/Employee

$23.52K

N/A

Employees

360

N/A

Net Income

$75.52M

-28.8%

EBITDA

$134.40M

-39.7%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$31.50M

+75.3%

Accounts Receivable

$92.46M

-26.2%

Inventory

$0.00

N/A

Long Term Debt

$11.47M

-88.7%

Short Term Debt

$45.04M

-30.7%

Return on Assets

-22.53%

N/A

Return on Invested Capital

-2.43%

N/A

Free Cash Flow

$25.53M

+55.4%

Operating Cash Flow

$25.73M

+55.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PSTVPlus Therapeutics, Inc.
$3.56-8.60%
INTSIntensity Therapeutics, Inc.
$5.70+0.19%
BMGLBasel Medical Group Ltd Ordinary Shares
$0.60-3.08%
RBOTVicarious Surgical Inc.
$0.73-9.88%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.33+0.00%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.31-0.02%

Questions About PIII

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.